Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers
Publication information:
Creason A, Egger J, Watson C, Sivagnanam S, Chin K, MacPherson K, Lin J-R, Chen Y-A, Johnson B, Feiler H, et al. Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers. bioRxiv. 2023:2023–09.